Cargando…
Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies
SIMPLE SUMMARY: There is currently no effective therapy available for triple-negative breast cancer. To look for potentially effective treatment, we used the 4T1 mouse model of triple-negative breast carcinoma to study the therapeutic response of TheraVac (an antitumor therapeutic vaccination regime...
Autores principales: | Nahar, Saifun, Huang, Yue, Nagy, Bethany A., Zebala, John A., Maeda, Dean Y., Rudloff, Udo, Oppenheim, Joost J., Yang, De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136945/ https://www.ncbi.nlm.nih.gov/pubmed/37190294 http://dx.doi.org/10.3390/cancers15082366 |
Ejemplares similares
-
Bacterial outer membrane vesicles-based therapeutic platform eradicates triple-negative breast tumor by combinational photodynamic/chemo-/immunotherapy
por: Li, Yongjiang, et al.
Publicado: (2022) -
Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021) -
Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021) -
Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy
por: Horn, Lucas A., et al.
Publicado: (2021) -
Prospects of Immunotherapy for Triple-Negative Breast Cancer
por: Qiu, Dan, et al.
Publicado: (2022)